Using novel biological therapies to target a tumor-specific isoform of HER2 for the treatment of advanced breast cancer
Active Project Grant Awarded Last action
- Award ID
- HT9425261E068
- Recipient
-
La Trobe University UEI MBAZZ7AHN377
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $669,102
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date 20% complete
- Place of performance
- Australia
Award details come from USAspending.gov.
About this award
The Defense Health Agency awarded La Trobe University $669,102 under the Military Medical Research and Development program (CFDA 12.420) on April 1, 2026, to develop novel biological therapies targeting a tumor-specific HER2 isoform for the treatment of advanced breast cancer. Work is performed in Australia through March 31, 2029. The award is classified as a Project Grant, an assistance type supporting basic, applied, and advanced biomedical research intended to transform health care for Service Members and the American public through innovative research and investigation of medical solutions.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Original award | $669,102 |
Quick answers
Who received award HT9425261E068?
HT9425261E068 was awarded to La Trobe University by Defense Health Agency (Department of Defense) on April 1, 2026.
How much is award HT9425261E068 worth?
$669,102 has been obligated on HT9425261E068.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award